Matrix metalloproteinase 14 and 19 expression is associated with thoracic aortic aneurysms

Journal of Thoracic and Cardiovascular Surgery

Volumn 144, Issue 2, 2012, Pages 459-466

  Jackson, Veronica ^a   Olsson, Therese ^b   Kurtovic, Sanela ^b   Folkersen, Lasse ^b   Paloschi, Valentina ^b   Wågsäter, Dick ^b   Franco Cereceda, Anders ^a   Eriksson, Per ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 21; MATRIX METALLOPROTEINASE 24; MATRIX METALLOPROTEINASE 25; MATRIX METALLOPROTEINASE 28; METALLOPROTEINASE; STROMELYSIN; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG;

ADULT; ADVENTITIA; AGED; AORTA VALVE DISEASE; ARTERIAL WALL THICKNESS; ARTICLE; ASCENDING AORTA; BICUSPID AORTIC VALVE; BODY SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXON; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA ANEURYSM; TRICUSPID AORTIC VALVE; UPREGULATION;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, THORACIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, SECRETED; MICROARRAY ANALYSIS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84863986164     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.08.043     Document Type: Article

References (25)

1. C. Ward Clinical significance of the bicuspid aortic valve Heart 83 2000 81 85
2. T.M. Tadros, M.D. Klein, and O.M. Shapira Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications Circulation 119 2009 880 890
3. W.G. Guntheroth A critical review of the American College of Cardiology/American Heart Association practice guidelines on bicuspid aortic valve with dilated ascending aorta Am J Cardiol 102 2008 107 110
4. V.A. McKusick, R.B. Logue, and H.T. Bahnson Association of aortic valvular disease and cystic medial necrosis of the ascending aorta; report of four instances Circulation 16 1957 188 194
5. P.W. Fedak, S. Verma, T.E. David, R.L. Leask, R.D. Weisel, and J. Butany Clinical and pathophysiological implications of a bicuspid aortic valve Circulation 106 2002 900 904
6. J.D. Raffetto, and R.A. Khalil Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease Biochem Pharmacol 75 2008 346 359
7. P.W. Fedak, M.P. de Sa, S. Verma, N. Nili, P. Kazemian, and J. Butany Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation J Thorac Cardiovasc Surg 126 2003 797 806
8. J.S. Ikonomidis, J.A. Jones, J.R. Barbour, R.E. Stroud, L.L. Clark, and B.S. Kaplan Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves J Thorac Cardiovasc Surg 133 2007 1028 1036
9. J.A. Jones, R.E. Stroud, B.S. Kaplan, A.M. Leone, J.E. Bavaria, and J.H. Gorman 3rd Differential protein kinase C isoform abundance in ascending aortic aneurysms from patients with bicuspid versus tricuspid aortic valves Circulation 116 11 Suppl 2007 I144 I149
10. A. Della Corte, C. Quarto, C. Bancone, C. Castaldo, F. Di Meglio, and D. Nurzynka Spatiotemporal patterns of smooth muscle cell changes in ascending aortic dilatation with bicuspid and tricuspid aortic valve stenosis: focus on cell-matrix signaling J Thorac Cardiovasc Surg 135 2008 8 18
11. K.D. Rizas, N. Ippagunta, and M.D. Tilson III Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm Cardiol Rev 17 2009 201 210
12. J.O. Stracke, M. Hutton, M. Stewart, A.M. Pendás, B. Smith, and C. López-Otin Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme J Biol Chem 275 2000 14809 14816
13. G. Murphy, V. Knauper, S. Cowell, R. Hembry, H. Stanton, and G. Butler Evaluation of some newer matrix metalloproteinases Ann N Y Acad Sci 878 1999 25 39
14. C. Kolb, S. Mauch, H.H. Peter, U. Krawinkel, and R. Sedlacek The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient Immunol Lett 57 1997 83 88
15. V. Djonov, K. Hogger, R. Sedlacek, J. Laissue, and A. Draeger MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours J Pathol 195 2001 147 155
16. T. Takino, H. Miyamori, Y. Watanabe, K. Yoshioka, M. Seiki, and H. Sato Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration Cancer Res 64 2004 1044 1049
17. T. Klein, and R. Bischoff Physiology and pathophysiology of matrix metalloproteases Amino Acids 41 2011 271 290
18. L.F. Borges, Z. Touat, A. Leclercq, A.A. Zen, G. Jondeau', and B. Franc Tissue diffusion and retention of metalloproteinases in ascending aortic aneurysms and dissections Hum Pathol 40 2009 306 313
19. G.J. Koullias, P. Ravichandran, D.P. Korkolis, D.L. Rimm, and J.A. Elefteriades Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections Ann Thorac Surg 78 2004 2106 2110 discussion 2110-1
20. K. Ahokas, J. Lohi, H. Lohi, O. Elomaa, M.L. Karjalainen-Lindsberg, and J. Kere Matrix metalloproteinase-21, the human orthologue for XMMP, is expressed during fetal development and in cancer Gene 301 2002 31 41
21. T. Skoog, K. Ahokas, C. Orsmark, L. Jeskanen, K. Isaka, and U. Saarialho-Kere MMP-21 is expressed by macrophages and fibroblasts in vivo and in culture Exp Dermatol 15 2006 775 783
22. T. Kuivanen, K. Ahokas, S. Virolainen, T. Jahkola, E. Hölttä, and O. Saksela MMP-21 is upregulated at early stages of melanoma progression but disappears with more aggressive phenotype Virchows Arch 447 2005 954 960
23. V.O. Bister, M.T. Salmela, M.L. Karjalainen-Lindsberg, J. Uria, J. Lohi, and P. Puolakkainen Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer Dig Dis Sci 49 2004 653 661
24. D. Bonderman, E. Gharehbaghi-Schnell, G. Wollenek, G. Maurer, H. Baumgartner, and I.M. Lang Mechanisms underlying aortic dilatation in congenital aortic valve malformation Circulation 99 1999 2138 2143
25. K. Ahokas, J. Lohi, S.A. Illman, E. Llano, O. Elomaa, and U. Impola Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-beta1 in keratinocytes Lab Invest 83 2003 1887 1899